DK116487D0 - Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser. - Google Patents

Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.

Info

Publication number
DK116487D0
DK116487D0 DK116487A DK116487A DK116487D0 DK 116487 D0 DK116487 D0 DK 116487D0 DK 116487 A DK116487 A DK 116487A DK 116487 A DK116487 A DK 116487A DK 116487 D0 DK116487 D0 DK 116487D0
Authority
DK
Denmark
Prior art keywords
protein
procedure
hybrid
polypeptime
epitop
Prior art date
Application number
DK116487A
Other languages
English (en)
Other versions
DK116487A (da
Inventor
Maurice Hofnung
Alain Charbit
Jean-Claude Boulain
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8603322A external-priority patent/FR2595374B1/fr
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Publication of DK116487D0 publication Critical patent/DK116487D0/da
Publication of DK116487A publication Critical patent/DK116487A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK116487A 1986-03-07 1987-03-06 Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser. DK116487A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8603322A FR2595374B1 (fr) 1986-03-07 1986-03-07 Procede pour exposer un epitope au sein d'une proteine distincte au sein d'une structure polypeptidique distincte, supportee ou non, et les produits obtenus
US1379687A 1987-02-12 1987-02-12

Publications (2)

Publication Number Publication Date
DK116487D0 true DK116487D0 (da) 1987-03-06
DK116487A DK116487A (da) 1987-09-08

Family

ID=26225070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK116487A DK116487A (da) 1986-03-07 1987-03-06 Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.

Country Status (4)

Country Link
EP (1) EP0242243B1 (da)
CA (1) CA1324333C (da)
DE (1) DE3786294T2 (da)
DK (1) DK116487A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
US5976839A (en) * 1987-03-13 1999-11-02 Bioenterprises Pty Limited Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
US5045447A (en) * 1989-03-15 1991-09-03 Minson Anthony C Method of producing antibodies to HPV
FR2648713B1 (fr) * 1989-06-26 1994-06-10 Commissariat Energie Atomique Proteines hybrides entre une enzyme extracytoplasmique et une autre proteine, leur procede de preparation, ainsi que leur application comme agent de diagnostic
JP2002065283A (ja) * 2000-06-12 2002-03-05 Wako Pure Chem Ind Ltd ハイブリッド酵素およびその用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2551456B1 (fr) * 1983-09-06 1985-12-06 Pasteur Institut Vecteur modifie par une partie au moins, sinon la totalite, du gene lam b et micro-organismes transformes par ce vecteur, et rendus aptes a synthetiser une proteine de membrane externe determinee, codee par un inserat egalement contenu dans ledit vecteur

Also Published As

Publication number Publication date
DE3786294T2 (de) 1993-09-30
EP0242243B1 (en) 1993-06-23
DK116487A (da) 1987-09-08
EP0242243A1 (en) 1987-10-21
CA1324333C (en) 1993-11-16
DE3786294D1 (de) 1993-07-29

Similar Documents

Publication Publication Date Title
DK2189D0 (da) Kimaere antistoffer samt deres fremstilling og anvendelse
FI894144A7 (fi) Startanordning med en kontinuerlig eller pulsformig ingaong foer test.
NO913524D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.
DK537087A (da) Fremgangsmaade til modificering af lipid-strukturen i cellemembraner samt praeparat til anvendelse herved
DK164973C (da) Undersoegelsesmetode til bestemmelse af 1,25-dihydroxy vitamin d og saet til brug ved denne metode
NO882917L (no) Fusjonsproteiner og partikler.
DK134089D0 (da) Vaske-, blege- og/eller rensepraeparater samt fremgangsmaade til fremstilling af disse
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
DK162929C (da) Mappe eller lignende samt fremgangsmaade og apparat til fremstilling heraf
IL70746A0 (en) Specific cea-family antigens,antibodies specific thereto and methods for the use thereof
DK116487A (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
NO892269L (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
DK494787A (da) Fremgangsmaade til bestemmelse af igm- og iga-immuno-globuliner og reagenser til anvendelse ved fremgangsmaaden
DK21586A (da) Antigener og antistoffer samt praeparater indeholdende disse
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
DK473583D0 (da) Fremgangsmade til indevejning af maelk i maelketankvogne, og maelketankvogn til udfoerelse af fremgangsmaden
SE7704575L (sv) Forfarande for anvendning av atminstone delvis jesta avfall genom biologisk upparbetning samt anleggning for genomforande av forfarandet
EP0274847A3 (en) A-associated h-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
DK70488D0 (da) Fremgangsmaade til paavisning af antistoffer i blod, samt membran og test-saet til anvendelse ved udoevelse af fremgangsmaaden
DK221388A (da) Garvemiddel samt fremgangsmaade til garvning
DK221488D0 (da) Garvemidler samt fremgangsmaade til garvning
NO930433D0 (no) Fremgangsmaate for rengjoering og avfetting, celleemulgerende forblanding for anvendelse ved fremgangsmaaten, samt denerholdte emulsjon
NO873154D0 (no) Spesifikke monoklonale antistoffer mot overflatereseptor for ige og hybridcellelinjer som produserer disse antistoffer og anvendelse derav.
DK120784A (da) Fremgangsmaade til rensning af mikrobielle proteinisolater samt deres anvendelse
DK316089D0 (da) Fremgangsmaade til paavisning af antistoffer eller antigener i et testfluidum samt proevesaet til anvendelse ved fremgangsmaaden

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment